Covalon Technologies (OTCMKTS:CVALF) Shares Down 1.3% – What’s Next?

Covalon Technologies Ltd. (OTCMKTS:CVALF) shares dropped 1.3% during trading on Thursday . The company traded as low as $1.54 and last traded at $1.54. Approximately 800 shares traded hands during mid-day trading, a decline of 85% from the average daily volume of 5,312 shares. The stock had previously closed at $1.56.

Covalon Technologies Price Performance

The firm has a 50-day moving average of $1.45 and a 200-day moving average of $1.34. The stock has a market cap of $42.53 million, a PE ratio of 38.51 and a beta of 0.62.

Covalon Technologies (OTCMKTS:CVALF) last released its earnings results on Thursday, May 21st. The company reported $0.03 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.01 by $0.02. Covalon Technologies had a return on equity of 5.74% and a net margin of 5.05%.The firm had revenue of $6.27 million during the quarter, compared to analysts’ expectations of $6.70 million.

Covalon Technologies Company Profile

Covalon Technologies Ltd. (OTCMKTS:CVALF) is a Canadian medical device and life sciences company specializing in advanced wound care and infection prevention solutions. Based in Toronto, Ontario, Covalon leverages proprietary photochemical bonding technology to create antimicrobial and anti-adhesion polymer coatings for a range of medical devices and wound dressings. The company’s core focus is on reducing surgical site infections and improving healing outcomes through innovative biomaterials.

The company’s product portfolio comprises hydrogel-based wound dressings and polymer-coated medical device components.